The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Open accessAbstract
Traditionally, vaccines have been developed by cultivating infectious agents and isolating the inactivated whole pathogen or some of its purified components. 20 years ago, reverse vaccinology enabled vaccine discovery and design based on information deriving from the sequence of microbial genomes rather than via the growth of pathogens. Today, the high throughput discovery of protective human antibodies, sequencing of the B cell repertoire, and the increasing structural characterization of protective antigens and epitopes provide the molecular and mechanistic understanding to drive the discovery of novel vaccines that were previously impossible. We are entering a “reverse vaccinology 2.0” era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whole-Genome Random Sequencing and Assembly of Haemophilus influenzae Rd
Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F., Kerlavage, A. R., Bult, C. J., Tomb, J.-F., Dougherty, B. A., Merrick, J. M., et al. (1995) · Science · doi:10.1126/science.7542800 · Cited by 5,654
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773 · cited 2×
“RSV is the main viral cause of severe respiratory tract disease in children worldwide (Nair et al., 2010) and also afflicts elderly and immunocompromised adults (Falsey et al., 2005).”
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043951 · Cited by 2,226
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
The IMpact-RSV Study Group (1998) · Pediatrics · doi:10.1542/peds.102.3.531 · Cited by 1,961
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Self-citationAntibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Victora, G. D., Schwickert, T. A., Fooksman, D. R., Kamphorst, A. O., Meyer-Hermann, M., Dustin, M. L., & Nussenzweig, M. C. (2010) · Cell · doi:10.1016/j.cell.2010.10.032 · Cited by 1,238
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203 · cited 5×
“However, the appropriateness of the HA stem region as a component in a universal flu vaccine was recently confirmed by the finding that bNAbs against this region of HA can be selected from human subjects after infection or vaccination (Kashyap et al., 2008; Throsby et al., 2008; Ekiert et al., 2009 Ekiert et al., , 20…”
BackgroundInfluentialSequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126
Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K., Larsen, C., Zheng, N.-Y., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,025
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Highly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 866
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., Kremer, G., Nogueira, L., Braunschweig, M., Scheid, J. F., et al. (2015) · Nature · doi:10.1038/nature14411 · Cited by 767
Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Rappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 704
Self-citationHemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C.-J., Kanekiyo, M., Kong, W.-P., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., et al. (2015) · Nature Medicine · doi:10.1038/nm.3927 · Cited by 699
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Self-citationBurton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Barouch, D. H., Whitney, J. B., Moldt, B., Klein, F., Oliveira, T. Y., Liu, J., Stephenson, K. E., Chang, H.-W., Shekhar, K., Gupta, S., et al. (2013) · Nature · doi:10.1038/nature12744 · Cited by 644
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Impagliazzo, A., Milder, F., Kuipers, H., Wagner, M. V., Zhu, X., Hoffman, R. M. B., van Meersbergen, R., Huizingh, J., Wanningen, P., Verspuij, J., et al. (2015) · Science · doi:10.1126/science.aac7263 · Cited by 600
Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Proof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Balazs, A. B., Chen, J., Hong, C. M., Rao, D. S., Yang, L., & Baltimore, D. (2012) · Nature · doi:10.1038/nature10660 · Cited by 545
HIV-1 neutralizing antibodies induced by native-like envelope trimers
Sanders, R. W., van Gils, M. J., Derking, R., Sok, D., Ketas, T. J., Burger, J. A., Ozorowski, G., Cupo, A., Simonich, C., Goo, L., et al. (2015) · Science · doi:10.1126/science.aac4223 · Cited by 496
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Lynch, R. M., Boritz, E., Coates, E. E., DeZure, A., Madden, P., Costner, P., Enama, M. E., Plummer, S., Holman, L., Hendel, C. S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5752 · Cited by 465
Antibodies in HIV-1 Vaccine Development and Therapy
Klein, F., Mouquet, H., Dosenovic, P., Scheid, J. F., Scharf, L., & Nussenzweig, M. C. (2013) · Science · doi:10.1126/science.1241144 · Cited by 457
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Shingai, M., Nishimura, Y., Klein, F., Mouquet, H., Donau, O. K., Plishka, R., Buckler-White, A., Seaman, M., Piatak, M., Lifson, J. D., et al. (2013) · Nature · doi:10.1038/nature12746 · Cited by 455
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 437
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Mouquet, H., Scheid, J. F., Zoller, M. J., Krogsgaard, M., Ott, R. G., Shukair, S., Artyomov, M. N., Pietzsch, J., Connors, M., Pereyra, F., et al. (2010) · Nature · doi:10.1038/nature09385 · Cited by 427
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Jardine, J. G., Ota, T., Sok, D., Pauthner, M., Kulp, D. W., Kalyuzhniy, O., Skog, P. D., Thinnes, T. C., Bhullar, D., Briney, B., et al. (2015) · Science · doi:10.1126/science.aac5894 · Cited by 420
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
Huang, J., Kang, B. H., Pancera, M., Lee, J. H., Tong, T., Feng, Y., Imamichi, H., Georgiev, I. S., Chuang, G.-Y., Druz, A., et al. (2014) · Nature · doi:10.1038/nature13601 · Cited by 420
Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404
Self-citationIdentification of human neutralizing antibodies that bind to complex epitopes on dengue virions
de Alwis, R., Smith, S. A., Olivarez, N. P., Messer, W. B., Huynh, J. P., Wahala, W. M. P. B., White, L. J., Diamond, M. S., Baric, R. S., Crowe, J. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200566109 · Cited by 390
Influenza Vaccines for the Future
Lambert, L. C., & Fauci, A. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1002842 · Cited by 389
Antibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins
McLellan, J. S., Ray, W. C., & Peeples, M. E. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-38919-1_4 · Cited by 380
Self-assembling protein nanoparticles in the design of vaccines
López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.11.001 · Cited by 353
Self-citationMacagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G., Sallusto, F., & Lanzavecchia, A. (2010) · Journal of Virology · doi:10.1128/jvi.01809-09 · Cited by 326
Kwakkenbos, M. J., Diehl, S. A., Yasuda, E., Bakker, A. Q., van Geelen, C. M. M., Lukens, M. V., van Bleek, G. M., Widjojoatmodjo, M. N., Bogers, W. M. J. M., Mei, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2071 · Cited by 300
Swanson, K. A., Settembre, E. C., Shaw, C. A., Dey, A. K., Rappuoli, R., Mandl, C. W., Dormitzer, P. R., & Carfi, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106536108 · Cited by 285
Self-citationHai, R., Krammer, F., Tan, G. S., Pica, N., Eggink, D., Maamary, J., Margine, I., Albrecht, R. A., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00137-12 · Cited by 278
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Corti, D., Bianchi, S., Vanzetta, F., Minola, A., Perez, L., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B. J., et al. (2013) · Nature · doi:10.1038/nature12442 · Cited by 278
Magro, M., Mas, V., Chappell, K., Vázquez, M., Cano, O., Luque, D., Terrón, M. C., Melero, J. A., & Palomo, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115941109 · Cited by 271
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Dosenovic, P., von Boehmer, L., Escolano, A., Jardine, J., Freund, N. T., Gitlin, A. D., McGuire, A. T., Kulp, D. W., Oliveira, T., Scharf, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.003 · Cited by 263
Convergent Antibody Signatures in Human Dengue
Parameswaran, P., Liu, Y., Roskin, K. M., Jackson, K. K. L., Dixit, V. P., Lee, J.-Y., Artiles, K. L., Zompi, S., Vargas, M. J., Simen, B. B., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.008 · Cited by 261
Jin, A., Ozawa, T., Tajiri, K., Obata, T., Kondo, S., Kinoshita, K., Kadowaki, S., Takahashi, K., Sugiyama, T., Kishi, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.1966 · Cited by 261
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Kashyap, A. K., Steel, J., Oner, A. F., Dillon, M. A., Swale, R. E., Wall, K. M., Perry, K. J., Faynboym, A., Ilhan, M., Horowitz, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801367105 · Cited by 252
Jackson, K. J. L., Liu, Y., Roskin, K. M., Glanville, J., Hoh, R. A., Seo, K., Marshall, E. L., Gurley, T. C., Moody, M. A., Haynes, B. F., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.05.013 · Cited by 251
Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo
Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W. H. I., Mosier, D. E., & Burton, D. R. (1999) · Immunity · doi:10.1016/s1074-7613(00)80043-6 · Cited by 243
Lavinder, J. J., Wine, Y., Giesecke, C., Ippolito, G. C., Horton, A. P., Lungu, O. I., Hoi, K. H., DeKosky, B. J., Murrin, E. M., Wirth, M. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317793111 · Cited by 242
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
Balazs, A. B., Ouyang, Y., Hong, C. M., Chen, J., Nguyen, S. M., Rao, D. S., An, D. S., & Baltimore, D. (2014) · Nature Medicine · doi:10.1038/nm.3471 · Cited by 237
A method for identification of HIV gp140 binding memory B cells in human blood
Scheid, J. F., Mouquet, H., Feldhahn, N., Walker, B. D., Pereyra, F., Cutrell, E., Seaman, M. S., Mascola, J. R., Wyatt, R. T., Wardemann, H., et al. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.11.012 · Cited by 214
Krause, J. C., Tsibane, T., Tumpey, T. M., Huffman, C. J., Basler, C. F., & Crowe, J. E. (2011) · Journal of Virology · doi:10.1128/jvi.00700-11 · Cited by 204
Structural basis of respiratory syncytial virus neutralization by motavizumab
McLellan, J. S., Chen, M., Kim, A., Yang, Y., Graham, B. S., & Kwong, P. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1723 · Cited by 182
A common solution to group 2 influenza virus neutralization
Friesen, R. H. E., Lee, P. S., Stoop, E. J. M., Hoffman, R. M. B., Ekiert, D. C., Bhabha, G., Yu, W., Juraszek, J., Koudstaal, W., Jongeneelen, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319058110 · Cited by 182
A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
O’Ryan, M., Stoddard, J., Toneatto, D., Wassil, J., & Dull, P. M. (2014) · Drugs · doi:10.1007/s40265-013-0155-7 · Cited by 172
Structure-based antigen design: a strategy for next generation vaccines
Dormitzer, P. R., Ulmer, J. B., & Rappuoli, R. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.08.002 · Cited by 169
Self-citationIsolation of human monoclonal antibodies from peripheral blood B cells
Huang, J., Doria-Rose, N. A., Longo, N. S., Laub, L., Lin, C.-L., Turk, E., Kang, B. H., Migueles, S. A., Bailer, R. T., Mascola, J. R., et al. (2013) · Nature Protocols · doi:10.1038/nprot.2013.117 · Cited by 168
Gavillet, B. M., Eberhardt, C. S., Auderset, F., Castellino, F., Seubert, A., Tregoning, J. S., Lambert, P., Gregorio, E. D., Giudice, G. D., & Siegrist, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402071 · Cited by 150
Structural vaccinology starts to deliver
Dormitzer, P. R., Grandi, G., & Rappuoli, R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2893 · Cited by 143
Self-citationBabcook, J. S., Leslie, K. B., Olsen, O. A., Salmon, R. A., & Schrader, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7843 · Cited by 132
Identification of Antigen-Specific B Cell Receptor Sequences Using Public Repertoire Analysis
Trück, J., Ramasamy, M., Galson, J. D., Rance, R., Parkhill, J., Lunter, G. A., Pollard, A. J., & Kelly, D. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401405 · Cited by 126
Kabanova, A., Perez, L. H., Lilleri, D., Marcandalli, J., Agatic, G., Becattini, S., Preite, S., Fuschillo, D., Percivalle, E., Sallusto, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415310111 · Cited by 122
Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
Liljeroos, L., Malito, E., Ferlenghi, I., & Bottomley, M. J. (2015) · Journal of Immunology Research · doi:10.1155/2015/156241 · Cited by 115
Self-citationMcLellan, J. S., Correia, B. E., Chen, M., Yang, Y., Graham, B. S., Schief, W. R., & Kwong, P. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.044 · Cited by 105
New approaches to HIV vaccine development
Haynes, B. F. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.05.007 · Cited by 92
Secondary Immunization Generates Clonally Related Antigen-Specific Plasma Cells and Memory B Cells
Frölich, D., Giesecke‐Thiel, C., Mei, H. E., Reiter, K., Daridon, C., Lipsky, P. E., & Dörner, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000911 · Cited by 91
Schneemann, A., Speir, J. A., Tan, G. S., Khayat, R., Ekiert, D. C., Matsuoka, Y., & Wilson, I. A. (2012) · Journal of Virology · doi:10.1128/jvi.01694-12 · Cited by 82
Wen, Y., Monroe, J. E., Linton, C. E., Archer, J. F., Beard, C. W., Barnett, S. W., Palladino, G., Mason, P. W., Carfí, A., & Lilja, A. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.004 · Cited by 79
Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire
Wine, Y., Horton, A. P., Ippolito, G. C., & Georgiou, G. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.009 · Cited by 76
Protein Crystallography in Vaccine Research and Development
Malito, E., Carfí, A., & Bottomley, M. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613106 · Cited by 69
Self-citationKolibab, K., Smithson, S. L., Rabquer, B. J., Khuder, S., & Westerink, M. A. J. (2005) · Infection and Immunity · doi:10.1128/iai.73.11.7465-7476.2005 · Cited by 65
Vaccines: Science, health, longevity, and wealth
Rappuoli, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413559111 · Cited by 42
Self-citationProspects for Defined Epitope Vaccines for Respiratory Syncytial Virus
Anderson, R., Huang, Y. Y., & Langley, J. M. (2010) · Future Microbiology · doi:10.2217/fmb.10.22 · Cited by 36
Systems analysis of adaptive immunity by utilization of high-throughput technologies
Reddy, S. T., & Georgiou, G. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.015 · Cited by 26
High throughput cellular screens to interrogate the human T and B cell repertoires
Corti, D., Sallusto, F., & Lanzavecchia, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.04.006 · Cited by 21
Cited by
Ecology and evolution of Mycobacterium tuberculosis
Gagneux, S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.8 · Cited by 599
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Self-citationEmerging Concepts and Technologies in Vaccine Development
Brisse, M., Vrba, S. M., Kirk, N., Liang, Y., & Ly, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583077 · Cited by 323
Designing spatial and temporal control of vaccine responses
Roth, G. A., Picece, V. C. T. M., Ou, B. S., Luo, W., Pulendran, B., & Appel, E. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00372-2 · Cited by 316
EMA Committee for Medicinal Products for Veterinary Use (CVMP) and EFSA Panel on Biological Hazards (BIOHAZ), Murphy, D., Ricci, A., Auce, Z., Beechinor, J. G., Bergendahl, H., Breathnach, R., Bureš, J., Duarte Da Silva, J. P., Hederová, J., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4666 · Cited by 314
Metadata
- Authors
- Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & De Gregorio, E.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-03-28
- Volume
- 213
- Issue
- 4
- Pages
- 469-481
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2323929490
- Cited by
- 435
- References
- 95
- FWCI
- 17.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.